V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330012935 | 330003632 | 0 | 46.8 | Palliative (P) | 2018-05-10 | 2018-05-11 | METHOTREXATE | N | N | 330005520 | METHOTREXATE |
| 330012936 | 330003646 | 1.63 | 118.1 | Curative (C) | 2015-08-25 | 2016-10-29 | Mifamurtide weeks 1-12 | null | N | 330005587 | MIFAMURTIDE |
| 330012937 | 330007964 | 1.66 | 96.3 | Curative (C) | 2018-05-16 | 2018-07-15 | EW EuroEwing 2012 Arm B VDC | N | N | 330005616 | TRIAL |
| 330012938 | 330003663 | 1.79 | 95.5 | Adjuvant (A) | null | 2018-03-02 | METHOTREXATE | N | null | 330005682 | METHOTREXATE |
| 330012939 | 330003685 | 1.77 | null | Curative (C) | 2018-03-24 | 2018-04-05 | OST Euramos 1 Closed Trial - A | Y | N | 330005732 | DOXORUBICIN |
| 330012940 | 330003688 | 1.67 | 31 | Curative (C) | 2017-11-19 | 2018-01-04 | Cisplatin | 01 | N | 330005735 | CISPLATIN |
| 330012941 | 330003705 | 0 | 86.05 | null | 2017-04-27 | 2017-07-05 | Cisplatin | 02 | Y | 330005896 | CISPLATIN |
| 330012942 | 330003709 | 1.71 | 66.8 | null | 2019-06-08 | 2019-07-03 | METHOTREXATE | N | N | 330005922 | METHOTREXATE |
| 330012943 | 330003728 | null | null | Curative (C) | null | 2015-12-21 | MIFAMURTIDE | N | null | 330006006 | MIFAMURTIDE |
| 330012944 | 330003742 | 1.66 | 83.05 | Palliative (P) | null | 2014-03-29 | CNS Medbl HR Cyclo+Vinc | null | null | 330006058 | TRIAL |
| 330012945 | 330003751 | 0 | 81 | Curative (C) | null | 2014-11-03 | R2W trial | 02 | N | 330006926 | TRIAL |
| 330012946 | 330003755 | 1.88 | 57.4 | Curative (C) | 2013-05-25 | 2014-03-12 | OST Euramos 1 Closed Trial - IE | null | null | 330007195 | TRIAL |
| 330012947 | 330008030 | null | 41.8 | Curative (C) | null | 2017-07-04 | DOXORUBICIN | N | null | 330007214 | DOXORUBICIN |
| 330012948 | 330003765 | 1.82 | 85 | Curative (C) | null | 2014-10-28 | OST Euramos 1 Closed Trial - A | N | null | 330007247 | DOXORUBICIN |
| 330012949 | 330008035 | 1.77 | null | Not known (9) | 2016-07-05 | 2016-11-23 | Cisplatin 7 day | N | null | 330007251 | CISPLATIN |
| 330012950 | 330010365 | 1.52 | null | Adjuvant (A) | 2014-08-02 | 2014-08-03 | OST Euramos 1 Closed Trial - A | N | N | 330007359 | DOXORUBICIN |
| 330012951 | 330003815 | 1.93 | 61.6 | Curative (C) | null | 2017-03-21 | METHOTREXATE | 2 | N | 330007452 | METHOTREXATE |
| 330012952 | 330003822 | null | null | Palliative (P) | 2015-10-08 | 2015-10-12 | Trial Unspecified | N | null | 330007479 | TRIAL |
| 330012953 | 330003842 | null | 102.55 | Neo-adjuvant (N) | null | 2015-02-14 | DOXORUBICIN | 01 | N | 330007542 | DOXORUBICIN |
| 330012954 | 330008096 | null | 73.6 | Adjuvant (A) | 2017-08-03 | 2017-11-09 | METHOTREXATE | Y | null | 330007616 | METHOTREXATE |
| 330012955 | 330003886 | null | 49.8 | Curative (C) | 2015-10-24 | 2015-11-14 | EW EuroEwing 2012 Arm B IE | null | null | 330007676 | TRIAL |
| 330012956 | 330003897 | 1.7 | 49.8 | Curative (C) | 2016-11-26 | 2016-12-04 | MIFAMURTIDE | N | Y | 330007724 | MIFAMURTIDE |
| 330012957 | 330003905 | 1.81 | 87.4 | Adjuvant (A) | 2014-09-24 | 2018-01-24 | Mifamurtide weeks 1-12 | 1 | N | 330007739 | MIFAMURTIDE |
| 330012958 | 330003930 | 1.72 | 75.1 | Palliative (P) | 2016-11-08 | 2017-03-11 | METHOTREXATE | 2 | N | 330007899 | METHOTREXATE |
| 330012959 | 330003936 | 1.73 | 65.8 | Neo-adjuvant (N) | 2018-02-15 | 2018-04-17 | Cisplatin | N | N | 330007924 | CISPLATIN |
| 330012960 | 330003943 | 0 | 74.9 | Curative (C) | 2014-08-29 | 2014-08-30 | MIFAMURTIDE | N | N | 330007971 | MIFAMURTIDE |
| 330012961 | 330003961 | 1.7 | 70 | Curative (C) | 2018-12-18 | 2019-01-29 | Cisplatin | N | N | 330008049 | CISPLATIN |
| 330012962 | 330012782 | 1.76 | 31 | Neo-adjuvant (N) | 2017-05-23 | 2017-05-23 | OST Euramos 1 Closed Trial - IE | N | N | 330008090 | TRIAL |
| 330012963 | 330010436 | null | 57.8 | Adjuvant (A) | 2014-04-01 | 2014-04-02 | METHOTREXATE | 01 | N | 330008138 | METHOTREXATE |
| 330012964 | 330004000 | 1.58 | 61.1 | Adjuvant (A) | null | 2016-04-18 | Mifamurtide weeks 13-36 | 02 | N | 330008194 | MIFAMURTIDE |
| 330012965 | 330008186 | 0 | 56 | Palliative (P) | null | 2017-12-23 | DOXORUBICIN | Y | null | 330008235 | DOXORUBICIN |
| 330012966 | 330004028 | 1.82 | 57.7 | Curative (C) | 2017-12-27 | 2017-12-31 | Cisplatin | Y | N | 330008284 | CISPLATIN |
| 330012967 | 330004044 | 1.54 | 73.6 | Palliative (P) | 2017-11-19 | 2017-11-22 | EW EuroEwing 2012 Arm B VDC | null | null | 330008370 | TRIAL |
| 330012968 | 330004050 | 1.72 | null | Palliative (P) | 2016-09-18 | 2017-02-02 | Trial Unspecified | Y | N | 330008382 | TRIAL |
| 330012969 | 330004073 | null | null | Adjuvant (A) | 2015-04-07 | 2018-06-30 | Mifamurtide weeks 13-36 | N | N | 330008566 | MIFAMURTIDE |
| 330012970 | 330012395 | 1.61 | 50.4 | Palliative (P) | 2015-08-31 | 2016-02-06 | Trial Unspecified | N | N | 330008614 | TRIAL |
| 330012971 | 330008241 | 1.66 | 57 | Adjuvant (A) | 2016-10-22 | 2017-02-26 | MIFAMURTIDE | 1 | N | 330008905 | MIFAMURTIDE |
| 330012972 | 330008247 | 1.71 | 87.4 | Palliative (P) | 2015-12-16 | 2018-05-03 | Mifamurtide weeks 1-12 | 2 | N | 330008951 | MIFAMURTIDE |
| 330012973 | 330008251 | 1.73 | 62 | Curative (C) | 2018-04-30 | 2018-09-24 | Cisplatin | N | null | 330008977 | CISPLATIN |
| 330012974 | 330004130 | 1.73 | 19.5 | Palliative (P) | 2014-12-02 | 2014-12-02 | EW EuroEwing 2012 Arm B IE | 2 | N | 330009031 | TRIAL |
| 330012976 | 330004144 | 1.63 | 81.4 | Neo-adjuvant (N) | 2015-02-09 | 2015-06-22 | Carboplatin AUC 6 - 10 | N | N | 330009101 | CARBOPLATIN |
| 330012977 | 330004161 | 1.71 | 111.3 | Neo-adjuvant (N) | 2017-08-27 | 2017-09-25 | Docetaxel+Gemcitabine (no prior RT) | N | N | 330009184 | DOCETAXEL + GEMCITABINE |
| 330012978 | 330004173 | 1.55 | 42.7 | Palliative (P) | 2013-11-06 | 2013-12-13 | Docetaxel+Gemcitabine (no prior RT) | N | N | 330009253 | DOCETAXEL + GEMCITABINE |
| 330012981 | 330004209 | 0 | 72 | Neo-adjuvant (N) | 2018-02-07 | 2018-09-29 | ETOPOSIDE + IFOSFAMIDE | N | Y | 330009744 | ETOPOSIDE + IFOSFAMIDE |
| 330012982 | 330004213 | 1.78 | 82 | Disease modification (D) | 2018-09-04 | 2018-09-15 | Rituximab | Y | N | 330009753 | RITUXIMAB |
| 330012983 | 330004253 | 0 | null | Curative (C) | 2018-10-30 | 2018-10-30 | CARBOPLATIN | null | null | 330010745 | CARBOPLATIN |
| 330012984 | 330008335 | 1.53 | 44.45 | Curative (C) | 2016-10-13 | 2016-11-06 | DOCETAXEL + GEMCITABINE | null | null | 330010873 | DOCETAXEL + GEMCITABINE |
| 330012985 | 330004273 | 1.75 | null | Curative (C) | 2018-07-30 | 2018-08-04 | OST Euramos 1 Closed Trial - M | N | N | 330010902 | METHOTREXATE HIGH DOSE |
| 330012986 | 330004291 | null | 58.2 | null | 2018-03-31 | 2018-04-06 | Cetuximab 7 day (Cycle 1) | N | N | 330011005 | CETUXIMAB |
| 330012987 | 330004292 | 1.57 | 81 | Adjuvant (A) | 2017-01-20 | 2017-02-08 | CISPLATIN + FLUOROURACIL | N | N | 330011010 | CISPLATIN + FLUOROURACIL |